Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Pediatric Highlight
  • Published:

Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome

Abstract

Background:

The diagnostic criteria of the metabolic syndrome (MS) have been applied in studies of obese adults to estimate the metabolic risk-associated with obesity, even though no general consensus exists concerning its definition and clinical value. We reviewed the current literature on the MS, focusing on those studies that used the MS diagnostic criteria to analyze children, and we observed extreme heterogeneity for the sets of variables and cutoff values chosen.

Objectives:

To discuss concerns regarding the use of the existing definition of the MS (as defined in adults) in children and adolescents, analyzing the scientific evidence needed to detect a clustering of cardiovascular risk-factors. Finally, we propose a new methodological approach for estimating metabolic risk-factor clustering in children and adolescents.

Results:

Major concerns were the lack of information on the background derived from a child's family and personal history; the lack of consensus on insulin levels, lipid parameters, markers of inflammation or steato-hepatitis; the lack of an additive relevant effect of the MS definition to obesity per se. We propose the adoption of 10 evidence-based items from which to quantify metabolic risk-factor clustering, collected in a multilevel Metabolic Individual Risk-factor And CLustering Estimation (MIRACLE) approach, and thus avoiding the use of the current MS term in children.

Conclusion:

Pediatricians should consider a novel and specific approach to assessing children/adolescents and should not simply derive or adapt definitions from adults. Evaluation of insulin and lipid levels should be included only when specific references for the relation of age, gender, pubertal status and ethnic origin to health risk become available. This new approach could be useful for improving the overall quality of patient evaluation and for optimizing the use of the limited resources available facing to the obesity epidemic.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Reaven GM . Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.

    Article  CAS  PubMed  Google Scholar 

  2. McNeill AM, Rosamond WD, Girman CJ, Golden CH, Schmidt MI, East HE et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005; 28: 385–390.

    PubMed  Google Scholar 

  3. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA . Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070–1077.

    PubMed  Google Scholar 

  4. Lorenzo C, Okoloise M, Williams K, Stern MP, Heffner SM . The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003; 26: 3153–3159.

    PubMed  Google Scholar 

  5. Hansen B . The metabolic syndrome X. Ann NY Acad Sci 1999; 892: 1–24.

    CAS  PubMed  Google Scholar 

  6. World Health Organization. Definition, Diagnosis, and Classification of Diabetes Mellitus and its Complications: Report of a WHO Consultation. Geneva, World Health Org 1999.

  7. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab 2002; 28: 364–376.

    PubMed  Google Scholar 

  8. International Diabetes Federation. The IDF Consensus Worldwide Definition of the Metabolic Syndrome. Available from http://www.idf.org.

  9. Expert Panel on Detection. Evaluation and Treatment of high blood cholesterol in adults: executive summary of the third report of the National Cholesterol Education Program (NCEP), expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–2497.

  10. Gale EAM . The myth of the metabolic syndrome. Diabetologia 2005; 48: 1679–1683.

    PubMed  Google Scholar 

  11. Grundy SM . The metabolic syndrome still lives. Clin Chem 2005; 51: 1352–1357.

    CAS  PubMed  Google Scholar 

  12. Kahn R, Buse J, Ferrannini E, Stern M . The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the study of diabetes. Diabetes Care 2005; 28: 2289–2304.

    PubMed  Google Scholar 

  13. Reaven GM . The metabolic syndrome: is this diagnosis necessary? Am J Clin Nutr 2006; 83: 1237–1247.

    CAS  PubMed  Google Scholar 

  14. Grundy SM . Does a diagnosis of metabolic syndrome have value in clinical practice? Am J Clin Nutr 2006; 83: 1248–1251.

    CAS  PubMed  Google Scholar 

  15. Chen W, Srinivasan SR, Elkasabany A, Berenson GS . Cardiovascular risk factor clustering features of insulin resistance syndrome (syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults. The Bogalusa Heart Study. Am J Epidemiol 1999; 150: 667–674.

    CAS  PubMed  Google Scholar 

  16. Csabi G, Torok K, Jeges S, Molnar D . Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 2000; 159: 91–94.

    CAS  PubMed  Google Scholar 

  17. Moreno LA, Pineda I, Rodriguez G, Fleta J, Sarria A, Bueno M . Waist circumference for the screening of the metabolic syndrome in children. Acta Paediatr 2002; 91: 1307–1312.

    CAS  PubMed  Google Scholar 

  18. Cook S, Weitsman M, Auinger P, Nguyen M, Dietz WH . Prevalence of a metabolic syndrome phenotype in adolescence: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med 2003; 157: 821–827.

    PubMed  Google Scholar 

  19. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EY, Newburger JW, Rifai N . Prevalence of the metabolic syndrome in american adolescents: findings from the third National Health and Nutrition Examination Survey. Circulation 2004; 110: 2494–2497.

    PubMed  Google Scholar 

  20. Goodman E, Dolan LM, Morrison JA, Daniels SR . Factor analysis of clustered cardiovascular risks in adolescence. Obesity is the predominant correlate of risk among youth. Circulation 2005; 111: 1970–1977.

    PubMed  Google Scholar 

  21. Lambert M, Paradis G, O'Loughlin J, Delvin EE, Hanley JA, Levy E . Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes 2004; 28: 833–841.

    CAS  Google Scholar 

  22. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW et al. Obesity and metabolic syndrome in children and adolescents. N Engl J Med 2004; 350: 2362–2374.

    CAS  PubMed  Google Scholar 

  23. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI . The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab 2004; 89: 108–113.

    CAS  PubMed  Google Scholar 

  24. Duncan G, Li S, Zhou X-K . Prevalence and trends of a metabolic syndrome phenotype among US adolescents, 1999–2000. Diabetes Care 2004; 27: 2438–2443.

    PubMed  Google Scholar 

  25. Rodriguez-Moran M, Salazar-Vasquez B, Violante R, Guerrero-Romero F . Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care 2004; 27: 2516–2517.

    PubMed  Google Scholar 

  26. Boney CM, Verma A, Tucker R, Vohr BR . Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: e290–e296.

    PubMed  Google Scholar 

  27. Viner RM, Segal TY, Lichtarowicz-Krinska E, Hindmarsch P . Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child 2005; 90: 10–14.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Janssen I, Katzmarzyk PT, Srinivasan SR, Chen W, Malina RM, Bouchard C et al. Combined influence of body mass index and waist circumference on coronary artery disease risk factors among children and adolescents. Pediatrics 2005; 115: 1623–1630.

    PubMed  Google Scholar 

  29. Invitti C, Maffeis C, Gilardini L, Pontiggia B, Mazzilli G, Girola A et al. Metabolic syndrome in obese caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes 2006; 30: 627–633.

    CAS  Google Scholar 

  30. Retnakaran R, Zinman B, Connelly PW, Harris SB, Hanley AJ . Nontraditional cardiovascular risk factors in pediatric metabolic syndrome. J Pediatr 2006; 148: 176–182.

    PubMed  Google Scholar 

  31. Chi CH, Wang Y, Wilson DM, Robinson TN . Definition of metabolic syndrome in preadolescent girls. J Pediatr 2006; 148: 788–792.

    PubMed  Google Scholar 

  32. Lopez-Capape M, Alonso M, Colino E, Mustieles C, Corbaton J, Barrio R . Frequency of the metabolic syndrome in obese Spanish pediatric population. Eur J Endocrinol 2006; 155: 313–319.

    CAS  PubMed  Google Scholar 

  33. Fu JF, Liang L, Zou CC, Hong F, Wang CL, Wang XM et al. Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention. Int J Obes 2007; 31: 15–22.

    CAS  Google Scholar 

  34. Golley RK, Magarey AM, Steinback KS, Baur LA, Daniels LA . Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management study. Int J Obes 2006; 30: 853–860.

    CAS  Google Scholar 

  35. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM . Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr 2004; 145: 445–451.

    PubMed  Google Scholar 

  36. Chen W, Bao W, Begum S, Elkasabany A, Srinivasan SR, Berenson GS . Age-related patterns of the clustering of cardiovascular risk variables of syndrome X from childhood to young adulthood in a population made up of black and white subjects: the Bogalusa Heart Study. Diabetes 2000; 49: 1042–1048.

    CAS  PubMed  Google Scholar 

  37. Baumgartner RN, Roche AF, Guo S, Lohman TG, Boileau RA, Slaughter MH . Adipose tissue distribution: the stability of principal components by sex, ethnicity and maturation stage. Hum Biol 1986; 58: 719–735.

    CAS  PubMed  Google Scholar 

  38. Cheal KL, Abbasi F, Lamendola C, McLaughlin T, Reaven GM, Ford ES . Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. Diabetes 2004; 53: 1195–1200.

    CAS  PubMed  Google Scholar 

  39. Conus F, Allison DB, Rabasa-Lhoret R, St-Onge MP, St-Pierre DH, Tremblay-Lebeau A et al. Metabolic and behavioral characeristics of metabolically obese but normal-weight women. J Clin Endocrinol Metab 2004; 89: 5013–5020.

    CAS  PubMed  Google Scholar 

  40. de Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L . Normal-weight obese syndrome: early inflammation? Am J Clin Nutr 2007; 85: 40–45.

    CAS  PubMed  Google Scholar 

  41. Goodman E . Pediatric metabolic syndrome: smoke and mirrors or true magic? J Pediatr 2006; 148: 149–151.

    PubMed  Google Scholar 

  42. Jones K . The dilemma of the metabolic syndrome in children and adolescents: disease or distraction? Pediatric Diabetes 2006; 7: 311–321.

    PubMed  Google Scholar 

  43. Soergel M, Kirschstein M, Busch C . Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: a multicenter trial including 1141 subjects. J Pediatr 1997; 130: 178–184.

    CAS  PubMed  Google Scholar 

  44. Romics L, Szollar L, Zajkas G . Treatment of disturbances of fat metabolism associated with atherosclerosis. Hung Med J 1993; 134: 227–238.

    CAS  Google Scholar 

  45. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 Task Force Report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996; 98: 649–658.

  46. National Cholesterol Education Panel. Report of the Expert Panel on Blood Cholescterol Levels in Children and Adolescents. Bethesda, MD: National Institute of Health 1991. NIH Publication No. 91–2732.

  47. American Diabetes Association guideline. Type 2 diabetes in children and adolescents. Diabetes Care 2000; 23: 381–389.

  48. Zhu S, Wang Z, Heshka S, Heo M, Faith MS, Heymsfield SB . Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. Am J Clin Nutr 2002; 76: 743–749.

    CAS  PubMed  Google Scholar 

  49. The Lipid Research Clinics Program Epidemiology Committee. Plasma lipid distribution in selected North Am populations: the Lipid Research Clinics Program Prevalence Study. Circulation 1979; 60: 427–439.

  50. Kuczmarski RJ, Ogden CI, Grummer-Strawn LM, Flegal KM, Guo SS, Wei R et al. CDC growth charts: United States. Adv Data 2000; 314: 1–27.

    Google Scholar 

  51. NGHS Coordinating Center. NHLBI Growth and Health Study (NGHS) data monitoring report. Baltimore: Maryland Medical Research, 1998.

  52. Fernandez JR, Redden DT, Pietrobelli A, Allison DB . Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004; 145: 439–444.

    PubMed  Google Scholar 

  53. Hickman TB, Briefel RR, Carroll MD, Rifkind BM, Cleeman JI, Maurer KR et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med 1998; 27: 879–890.

    CAS  PubMed  Google Scholar 

  54. Bloomgarden ZT . Type 2 Diabetes in the young. Diabetes Care 2004; 27: 998–1010.

    PubMed  Google Scholar 

  55. Centers of Disease Control and Prevention. (www.cdc.gov/growthcharts).

  56. Task Force on Blood Pressure Control in Children. Report of the second task force on blood pressure control in children. Pediatrics 1987; 79: 1–25.

  57. American Academy of Pediatrics, National Cholesterol Education Program. Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 1992; 89: 525–564.

  58. Cole TJ, Freeman JV, Preece MA . Body mass index reference curves for the UK, 1990. Arch Dis Child 1995; 73: 25–29.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. Goran MI, Gower BA . Longitudinal study on pubertal insulin resistance. Diabetes 2001; 50: 2444–2450.

    CAS  PubMed  Google Scholar 

  60. World Health Organization Department of Noncommunicable Disease Surveillance. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. World Health Organization: Geneva, 1999.

  61. Chen W, Srinivasan SR, Li S, Xu J, Berenson GS . Metabolic syndrome variables at low levels in childhood are beneficially associated with adulthood cardiovascular risk: the Bogalusa Heart Study. Diabetes Care 2005; 28: 138–143.

    CAS  Google Scholar 

  62. Srinivasan SR, Meyers L, Berenson GS . Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study. Hypertension 2006; 48: 33–39.

    CAS  PubMed  Google Scholar 

  63. Barker DJP . Fetal origins of coronary heart disease. BMJ 1995; 311: 171–174.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Yajnik C . Interactions of perturbations in intrauterine growth and growth during childhood on the risk of adult-onset disease. Proc Nutr Soc 2000; 59: 257–265.

    CAS  PubMed  Google Scholar 

  65. Oken E, Gillman MW . Fetal origins of obesity. Obes Res 2003; 11: 496–506.

    PubMed  Google Scholar 

  66. Goran MI, Ball GDC, Cruz ML . Obesity and risk of type2 diabetes and cardiovascular disease in children and adolescents. J Clin Endocrinol Metab 2003; 88: 1417–1427.

    CAS  PubMed  Google Scholar 

  67. Caprio S . Insulin resistance in childhood obesity. J Ped End Metab 2002; 15: 487–492.

    CAS  Google Scholar 

  68. Huang T-K, Johnson MS, Gower BA, Goran MI . Effect of changes in fat distribution on the rates of change of insulin response in children. Obes Res 2002; 10: 978–984.

    CAS  PubMed  Google Scholar 

  69. Mansoub S, Chan MK, Adeli K . Gap analysis of pediatric reference intervals for risk biomarkers of cardiovascular disease and the metabolic syndrome. Clin Biochem 2006; 39: 569–587.

    CAS  PubMed  Google Scholar 

  70. Gilardini L, McTernan PG, Girola A, da Silva NF, Alberti L, Kumar S et al. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis 2006; 189: 401–407.

    CAS  PubMed  Google Scholar 

  71. Hoffman WH, Barbeau P, Litaker MS, Johnson MH, Howe CA, Gutin B . Tanner staging of secondary sexual characteristics and body composition, blood pressure, and insulin in black girls. Obes Res 2005; 13: 2195–2201.

    PubMed  Google Scholar 

  72. Frontini MG, Srinivasan SR, Berenson GS . Longitudinal changes in risk variables underlying metabolic syndrome X from childhood to young adulthood in female subjects with a history of early menarche: the Bogalusa Heart Study. Int J Obes 2003; 27: 1398–1404.

    CAS  Google Scholar 

  73. Li YP, Yang XG, Zhai FY, Piao JH, Zhao WH, Zhang J et al. Disease risks of childhood obesity in China. Biomed Environ Sci 2005; 18: 401–410.

    PubMed  Google Scholar 

  74. McLaughlin T, Allison G, Abbasi F, Lamendola C, Reaven GM . Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals. Metabolism 2004; 53: 495–499.

    CAS  PubMed  Google Scholar 

  75. Morrison JA, Aronson Friedman L, Harlan WR, Harlan LC, Barton BA, Schreiber GB et al. Development of the metabolic syndrome in black and white adolescent girls: a longitudinal assessment. Pediatrics 2005; 116: 1178–1182.

    PubMed  Google Scholar 

  76. Eisenmann JC, Welk GJ, Wickel EE, Blair SN, Aerobics Center Longitudinal Study. Stability of variables associated with the metabolic syndrome from adolescence to adulthood: the Aerobics Center Longitudinal Study. Am J Hum Biol 2004; 16: 690–696.

    PubMed  Google Scholar 

  77. Facchini F, Hollenbeck CB, Chen YN, Chen YD, Reaven GM . Demonstration of a relationship between while blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 1992; 232: 267–272.

    CAS  PubMed  Google Scholar 

  78. Koenig W, Sund M, Frohlich M, Fisher HG, Lowel H, Doring A et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984–1992. Circulation 1999; 99: 237–242.

    CAS  PubMed  Google Scholar 

  79. Imperatore G, Riccardi G, Iovine C, Rivellese AA, Vaccaro O . Plasma fibrinogen: a new factor of the metabolic syndrome: a population-based study. Diabetes Care 1998; 21: 649–654.

    CAS  PubMed  Google Scholar 

  80. Ford ES . C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999-2000. Circulation 2003; 108: 1053–1058.

    CAS  PubMed  Google Scholar 

  81. Retnakaran R, Hanley AJ, Connelly PW, Harris SB, Zinman B . Elevated C-reactive protein in Native Canadian children: an ominous early complication of childhood obesity. Diabetes Obes Metab 2006; 8: 483–491.

    CAS  PubMed  Google Scholar 

  82. Sbarbati A, Osculati F, Silvagni D, Benati D, Galie M, Camoglio FS et al. Obesity and inflammation: evidence for an elementary lesion. Pediatrics 2006; 117: 220–223.

    PubMed  Google Scholar 

  83. Perseghin G, Bonfanti R, Magni S, Lattuada G, De Cobelli F, Canu T et al. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease. Am J Physiol Endocrinol Metab 2006; 291: E697–E703.

    CAS  PubMed  Google Scholar 

  84. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X et al. Alanine aminotransferase levels and fatty liver in childhood obesity: association with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab 2006; 91: 4287–4294.

    CAS  PubMed  Google Scholar 

  85. Weitzman M, Cook S, Auinger P, Florin TA, Daniels S, Nguyen M et al. Tobacco smoke exposure is associated with metabolic syndrome in adolescents. Circulation 2005; 112: 862–869.

    CAS  PubMed  Google Scholar 

  86. Rosenthal M, Haskell WL, Solomon R, Widstrom A, Reaven GM . Demonstration of a relationship between level of physical training and insulin-stimulated glucose utilization in normal humans. Diabetes 1983; 32: 408–411.

    CAS  PubMed  Google Scholar 

  87. Stedman's Medical Dictionary 27th edn Baltimore, MD, Lippincott, Williams and Wilkins, 2000. p. 1746.

  88. Chew GT, Gan SK, Watts GF . Revisiting the metabolic syndrome. MJA 2006; 185: 445–449.

    PubMed  Google Scholar 

  89. McMillen IC, Robinson JS . Developmental origins of the metabolic syndrome: prediction, plasticity, and programming. Physiol Rev 2005; 85: 571–633.

    CAS  PubMed  Google Scholar 

  90. Groner JA, Joshi M, Bauer JA . Pediatric precursors of adult cardiovascular disease: noninvasive assessment of early vascular changes in children and adolescents. Pediatrics 2006; 118: 1683–1691.

    PubMed  Google Scholar 

  91. Weghuber D, Zaknun D, Nasel C, Willforth-Ehringer A, Muller T, Boriss-Riedl M et al. Early cerebrovascular disease in a 2-year-old with extreme obesity and complete metabolic syndrome due to feeding of excessively high amount of energy. Eur J Pediatr 2007; 166: 37–41.

    PubMed  Google Scholar 

  92. Lande MB, Carson NL, Roy J, Meagher CC . Effects of childhood primary hypertension on carotid intima media thickness: a matched control study. Hypertension 2006; 48: 40–44.

    CAS  PubMed  Google Scholar 

  93. Meyer AA, Kundt G, Steiner M, Schuff-Werner P, Kienast W . Impaired flow-mediated vasodilation, carotid artery intima-media thickening, and elevated endotelial plasma markers in obese children: the impact of cardiovascular risk factors. Pediatrics 2006; 117: 1560–1567.

    PubMed  Google Scholar 

  94. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R . Intima-media thickness in childhood obesity: relations to inflammatory marker, glucose metabolism, and blood pressure. Metabolism 2006; 55: 113–118.

    CAS  PubMed  Google Scholar 

  95. Genovesi S, Giussani M, Pieruzzi F, Vigorita F, Arcovio C, Cavuto S et al. Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight. J Hypertens 2005; 23: 493–497.

    CAS  PubMed  Google Scholar 

  96. Genovesi S, Pieruzzi F . Obesity-associated hypertension in childhood: a new epidemic problem. Curr Hypertens Rev 2006; 2: 199–206.

    Google Scholar 

  97. Kavey RW, Daniels SR, Lauer RM, Atkins DL, Hayman LL, Taubert K . American Heart Association Guidelines for primary prevention of Atherosclerotic Cardiovascular disease beginning in childhood. Circulation 2003; 107: 1562–1566.

    PubMed  Google Scholar 

  98. Speiser PW, Rudolf MCJ, Anhalt H, Camacho-Hubner C, Chiarelli F, Eliakim A et al. Consensus statement: childhood obesity. J Clin Endocrinol Metab 2005; 90: 1871–1887.

    CAS  PubMed  Google Scholar 

  99. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The Fourth Report on the Diagnosis, Evaluation, and Treatment of High Blood Pressure in Children and Adolescents. Pediatrics 2004; 114: 555–576.

  100. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH . Establising a standard definition of child overweight and obesity worldwide: international survey. BMI 2000; 320: 1–6.

    Google Scholar 

  101. Kobaissi HA, Weigensberg MJ, Ball GD, Cruz ML, Shaibi GQ, Goran MI . Relation between acanthosis nigricans and insulin sensitivity in overweight Hispanic children at risk for type 2 diabetes. Diabetes Care 2004; 27: 1412–1416.

    PubMed  Google Scholar 

  102. McCarthy HD, Jarrett KV, Crawley HF . The development of waist circumference percentiles in British children aged 5.0-16.9 y. Eur J Clin Nutr 2001; 55: 902–907.

    CAS  PubMed  Google Scholar 

  103. Moreno LA, Fleta J, Mur L, Rodriguez G, Sarria A, Bueno M . Waist circumference values in Spanish children. Gender related differences. Eur J Clin Nutr 1999; 53: 429–433.

    CAS  PubMed  Google Scholar 

  104. Eisenmann JC . Waist circumference percentiles for 7- to 15-year-old Australian children. Acta Paediatrica 2005; 94: 1182–1185.

    PubMed  Google Scholar 

  105. Katzmarzyk PT . Waist circumference percentiles for Canadian youth 11–18 year of age. Eur J Clin Nutr 2004; 58: 1011–1015.

    CAS  PubMed  Google Scholar 

  106. Lissau I, Overpeck MD, Ruan WJ, Due P, Holstein BE, Hediger ML . Body mass index and overweight in adolescents in 13 European countries, Israel, and the United States. Arch Pediatr Adolesc Med 2004; 158: 27–33.

    PubMed  Google Scholar 

  107. Brambilla P, Bedogni G, Moreno LA, Goran MI, Gutin B, Fox KR et al. Crossvalidation of anthropometry against magnetic resonance imaging for the assessment of visceral and subcutaneous adipose tissue in children. Int J Obes 2006; 30: 23–30.

    CAS  Google Scholar 

  108. Hirschler V, Aranda C, Calcagno MDL, Maccalini G, Jadzinsky M . Can waist circumference identify children with the metabolic syndrome? Arch Pediatr Adolesc Med 2005; 159: 740–744.

    PubMed  Google Scholar 

  109. Lee S, Bacha F, Gungor N, Arslanian SA . Waist circumference is an independent predictor of insulin resistance in black and white youths. J Pediatr 2006; 148: 188–194.

    CAS  PubMed  Google Scholar 

  110. Jolliffe CJ, Ianssen I . Distribution of lipoproteins by age and gender in adolescents. Circulation 2006; 114: 1056–1062.

    CAS  PubMed  Google Scholar 

  111. Srinivasan SR, Frontini MG, Xu J, Berenson GS . Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dislipidemia and other cardiovascular risks: the Bogalusa Heart Study. Pediatrics 2006; 118: 201–206.

    PubMed  Google Scholar 

  112. Sirtori CR, Fumagalli R . LDL-cholesterol lowering or HDL-cholesterol raising for cardiovascular prevention. A lesson from cholesterol turnover studies and other. Atherosclerosis 2006; 186: 1.11.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A Pietrobelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brambilla, P., Lissau, I., Flodmark, CE. et al. Metabolic risk-factor clustering estimation in children: to draw a line across pediatric metabolic syndrome. Int J Obes 31, 591–600 (2007). https://doi.org/10.1038/sj.ijo.0803581

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0803581

Keywords

This article is cited by

Search

Quick links